A Study of a 10-days Fenofibrate Treatment, or Until Discharge From Hospital, Among COVID-19 Infected Patients Requiring Hospitalization
Latest Information Update: 05 Apr 2024
At a glance
- Drugs Fenofibrate (Primary)
- Indications COVID-19 respiratory infection
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms FENOC
- 05 Apr 2024 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Apr 2022).
- 17 Apr 2022 Planned End Date changed from 1 Jun 2022 to 1 Jul 2022.
- 17 Apr 2022 Planned primary completion date changed from 1 Mar 2022 to 1 May 2022.